Live

Trump is digging in after China retaliated to his tariffs. See the latest updates.

Cboe UK SEK

AstraZeneca PLC (AZNS.XC)

Compare

1,414.50

-50.00

(-3.41%)

At close: 2:53:26 PM GMT+1

European Drug Regulator Approves AstraZeneca's Two Flagship Cancer Drugs For Breast And Lung Cancer Settings

The European Commission on Friday approved AstraZeneca Plc (NASDAQ:AZN) and Daiichi Sankyo's (OTC:DSKNY) Enhertu (trastuzumab deruxtecan) as a monotherapy for a type of breast cancer. The approval covers adult patients with unresectable or metastatic hormone receptor (HR)-positive, HER2-low or HER2-ultralow breast cancer who have received at least one endocrine therapy in the metastatic setting and who are not considered suitable for endocrine therapy as the next line of treatment. Also Read: FD

Benzinga 5 minutes ago

AZN
European Equities Spiral in Friday Trading Amid Global Selloff Sparked by US Tariffs

The European stock markets nosedived in Friday trading amid a global selloff sparked by newly impose

PREMIUM
MT Newswires 1 hour ago

LYG

HSBC

AZN
Daiichi and AstraZeneca’s Enhertu gains EC approval for breast cancers

The approval is supported by the outcomes of the Phase III DESTINYBreast06 trial.

Pharmaceutical Technology 3 hours ago

4568.T

AZN
Pharma Stock Roundup: FDA Nod to SNY, AZN & NVS, JNJ Talc Suits Failure

FDA approves SNY's hemophilia therapy, fitusiran, and NVS' rare kidney disease drug, Vanrafia.

Zacks 4 hours ago

AZN

SNY

PFE
AstraZeneca PLC's (LON:AZN) Stock Has Fared Decently: Is the Market Following Strong Financials?

AstraZeneca's (LON:AZN) stock up by 7.5% over the past three months. Since the market usually pay for a company’s...

Simply Wall St. 6 hours ago

AZN

AZNCF
Spirits, Swiss Watches, Sneakers: Global Stock-Market Winners and Losers from Tariffs

Here are some notable moves across sectors in global markets, following President Trump’s “Liberation Day” tariffs. Some investors turned to drink: Scotch producer Diageo and Aperol maker Campari were among the few risers in Europe. This is mostly about their imports from Mexico and Canada, brokers say, after the White House kept duty-free access to the U.S. for USMCA-compliant products.

The Wall Street Journal yesterday

NKE

AZN

AZNCF
How Trump's tariffs will impact your finances and the UK economy

Keir Starmer has admitted the US president's trade war will hurt the UK economy.

Yahoo Finance UK yesterday

LVMHF

LVMUY

GBPEUR=X
Trending tickers: Nvidia, Tesla, Nike, AstraZeneca and Standard Chartered

The latest investor updates on stocks that are trending on Thursday.

Yahoo Finance UK yesterday

GBPEUR=X

GBP=X

EUR=X
Q4 2024 AIM ImmunoTech Inc Earnings Call

Q4 2024 AIM ImmunoTech Inc Earnings Call

Thomson Reuters StreetEvents 2 days ago

AZN
AstraZeneca's Imfinzi Gets FDA Nod for Bladder Cancer Indication

The FDA approves AZN's sBLA seeking the expanded use of Imfinzi for adult patients with muscle-invasive bladder cancer.

Zacks 3 days ago

AZN
AstraZeneca’s AZD0780 cuts LDL-C by 50% in Phase IIb trial

The company reported results from the Phase IIb PURSUIT trial at ACC 2025.

Clinical Trials Arena 3 days ago

AZN

GLDAF
Trending tickers: Tesla, Moderna, Newsmax, Johnson & Johnson and Travis Perkins

The latest investor updates on stocks that are trending on Tuesday.

Yahoo Finance UK 3 days ago

^DJI

GBPEUR=X

GBP=X
FDA approves AstraZeneca’s Imfinzi combo for bladder cancer

The decision follows a priority review and is based on data from the Phase III NIAGARA trial.

Pharmaceutical Technology 3 days ago

AZN
Does AstraZeneca Have 'One Pill To Rule Them All' In Cholesterol?

AstraZeneca said Monday its experimental pill lowered "bad" LDL cholesterol by 51%. But AstraZeneca stock fell in line with pharma stocks.

Investor's Business Daily 3 days ago

NAMS

NAMSW

AZN
FDA Approves AstraZeneca's Imfinzi As First Perioperative Immunotherapy For Muscle-Invasive Bladder Cancer Patients

The U.S. Food and Drug Administration (FDA) on Monday approved AstraZeneca Plc's (NASDAQ:AZN) Imfinzi (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by Imfinzi as adjuvant monotherapy after radical cystectomy (surgery to remove the bladder) for adult patients with muscle-invasive bladder cancer (MIBC). The FDA approval was based on results from the NIAGARA Phase 3 trial. In a planned interim analysis, the Imfinzi-based perioperative regimen demonstr

Benzinga 3 days ago

AZN
AZD0780, a novel oral PCSK9 inhibitor, demonstrated significant LDL cholesterol (LDL-C) reduction in PURSUIT Phase IIb trial

WILMINGTON, Del., March 31, 2025--Positive results from the PURSUIT Phase IIb trial for AstraZeneca’s AZD0780 demonstrated a statistically significant low-density lipoprotein cholesterol (LDL-C) reduction when administered on top of standard-of-care statin therapy, as compared with placebo.1,2 AZD0780 is an investigational once-daily oral PCSK9 inhibitor for patients currently not reaching their LDL-C lowering goal despite standard-of-care-lipid lowering therapies such as statins.1,2

Business Wire 4 days ago

AZN

AZNCF
JNJ's Rybrevant-Lazcluze Combo Outshines AZN's Tagrisso in Lung Cancer

Study investigators expect that J&J's combo drug can extend overall survival by at least a year over the current standard of care in certain NSCLC patients.

Zacks 4 days ago

AZN

NVS
IMFINZI® (durvalumab) approved in the US as first and only perioperative immunotherapy for patients with muscle-invasive bladder cancer

WILMINGTON, Del., March 31, 2025--AstraZeneca’s IMFINZI® (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by IMFINZI as adjuvant monotherapy after radical cystectomy (surgery to remove the bladder) has been approved in the US for the treatment of adult patients with muscle-invasive bladder cancer (MIBC).

Business Wire 4 days ago

AZN

AZNCF
Is AstraZeneca (AZN) the Best ADR Stock to Buy According to Hedge Funds?

We recently compiled a list of the 12 Best ADR Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where AstraZeneca PLC (NASDAQ:AZN) stands against the other best ADR stocks. American Depositary Receipts (ADR) are US-listed securities that represent shares in foreign companies, allowing American investors […]

Insider Monkey 6 days ago

AZN
Brokers Suggest Investing in Astrazeneca (AZN): Read This Before Placing a Bet

The average brokerage recommendation (ABR) for Astrazeneca (AZN) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

Zacks 8 days ago

AZN

Performance Overview

Return	AZNS.XC	MSCI WORLD (^990100-USD-STRD)
YTD	0.00%	-9.45%
1-Year	0.00%	-0.85%
3-Year	+0.75%	+8.96%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Live

AstraZeneca PLC (AZNS.XC)

European Drug Regulator Approves AstraZeneca's Two Flagship Cancer Drugs For Breast And Lung Cancer Settings

European Equities Spiral in Friday Trading Amid Global Selloff Sparked by US Tariffs

Daiichi and AstraZeneca’s Enhertu gains EC approval for breast cancers

Pharma Stock Roundup: FDA Nod to SNY, AZN & NVS, JNJ Talc Suits Failure

AstraZeneca PLC's (LON:AZN) Stock Has Fared Decently: Is the Market Following Strong Financials?

Spirits, Swiss Watches, Sneakers: Global Stock-Market Winners and Losers from Tariffs

How Trump's tariffs will impact your finances and the UK economy

Trending tickers: Nvidia, Tesla, Nike, AstraZeneca and Standard Chartered

Q4 2024 AIM ImmunoTech Inc Earnings Call

AstraZeneca's Imfinzi Gets FDA Nod for Bladder Cancer Indication

AstraZeneca’s AZD0780 cuts LDL-C by 50% in Phase IIb trial

Trending tickers: Tesla, Moderna, Newsmax, Johnson & Johnson and Travis Perkins

FDA approves AstraZeneca’s Imfinzi combo for bladder cancer

Does AstraZeneca Have 'One Pill To Rule Them All' In Cholesterol?

FDA Approves AstraZeneca's Imfinzi As First Perioperative Immunotherapy For Muscle-Invasive Bladder Cancer Patients

AZD0780, a novel oral PCSK9 inhibitor, demonstrated significant LDL cholesterol (LDL-C) reduction in PURSUIT Phase IIb trial

JNJ's Rybrevant-Lazcluze Combo Outshines AZN's Tagrisso in Lung Cancer

IMFINZI® (durvalumab) approved in the US as first and only perioperative immunotherapy for patients with muscle-invasive bladder cancer

Is AstraZeneca (AZN) the Best ADR Stock to Buy According to Hedge Funds?

Brokers Suggest Investing in Astrazeneca (AZN): Read This Before Placing a Bet

Performance Overview

News

Life

Entertainment

Finance

Sports

New on Yahoo

Live

AstraZeneca PLC (AZNS.XC)

European Drug Regulator Approves AstraZeneca's Two Flagship Cancer Drugs For Breast And Lung Cancer Settings

European Equities Spiral in Friday Trading Amid Global Selloff Sparked by US Tariffs

Daiichi and AstraZeneca’s Enhertu gains EC approval for breast cancers

Pharma Stock Roundup: FDA Nod to SNY, AZN & NVS, JNJ Talc Suits Failure

AstraZeneca PLC's (LON:AZN) Stock Has Fared Decently: Is the Market Following Strong Financials?

Spirits, Swiss Watches, Sneakers: Global Stock-Market Winners and Losers from Tariffs

How Trump's tariffs will impact your finances and the UK economy

Trending tickers: Nvidia, Tesla, Nike, AstraZeneca and Standard Chartered

Q4 2024 AIM ImmunoTech Inc Earnings Call

AstraZeneca's Imfinzi Gets FDA Nod for Bladder Cancer Indication

AstraZeneca’s AZD0780 cuts LDL-C by 50% in Phase IIb trial

Trending tickers: Tesla, Moderna, Newsmax, Johnson & Johnson and Travis Perkins

FDA approves AstraZeneca’s Imfinzi combo for bladder cancer

Does AstraZeneca Have 'One Pill To Rule Them All' In Cholesterol?

FDA Approves AstraZeneca's Imfinzi As First Perioperative Immunotherapy For Muscle-Invasive Bladder Cancer Patients

​​AZD0780, a novel oral PCSK9 inhibitor, demonstrated significant LDL cholesterol (LDL-C) reduction in PURSUIT Phase IIb trial

JNJ's Rybrevant-Lazcluze Combo Outshines AZN's Tagrisso in Lung Cancer

IMFINZI® (durvalumab) approved in the US as first and only perioperative immunotherapy for patients with muscle-invasive bladder cancer

Is AstraZeneca (AZN) the Best ADR Stock to Buy According to Hedge Funds?

Brokers Suggest Investing in Astrazeneca (AZN): Read This Before Placing a Bet

AZD0780, a novel oral PCSK9 inhibitor, demonstrated significant LDL cholesterol (LDL-C) reduction in PURSUIT Phase IIb trial